ArticleClinical transplantation2026
Pancreas Transplantation in the Modern Era: Observations and Implications of Donor Pancreas Extraction Time.
Article in Clinical transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pancreas Transplantation in the Modern Era: Observations and Implications of Donor Pancreas Extraction Time.Clinical transplantation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There has been a worldwide reduction in pancreas transplant volume over the last decade. Understanding factors, such as procurement extraction time (ET), that play a key role in organ recovery can increase confidence in organ acceptance and improve organ utilization. All patients who underwent deceased donor pancreas transplantation at a single US center between January 2019 and August 2024 were stratified by ET and retrospectively reviewed. A total of 137 transplants were included in the analysis with 72 patients in the ET ≤ 40 min group and 65 patients in the ET > 40 min group. We found no significant difference in all-cause pancreas graft loss between the ET ≤ 40 min and ET > 40 min group (6.9% vs 12%; p = 0.482), but there was a higher readmission rate at 90 days in the ET ≤ 40 min group (60% vs 39%; p = 0.015) regardless of adjustments in multivariate analysis. We demonstrate for the first time at a US center that while ET is not associated with all-cause graft loss, it may impact postoperative outcomes such as readmission rates and could have important implications for the future of pancreas utilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.